Agile Therapeutics, Inc.

Bristol Myers Squibb Company and Sanofi recently joined the ranks of companies cutting costs and jobs in 2024, although not necessarily for the same reasons, as first quarter earnings season got un

At a time when the biopharma industry is still suffering from the financing hangover of 2022, investment in women’s health is on the upswing. While company founders, investors and scientists have been

The contraceptive market is one famously defined by its lack of innovation. Despite pioneering attempts by researchers to bring new contraceptive options to market – particularly efforts to develop a

The last week of February wasn’t an ideal time for any company to launch an initial public offering, with US stock market indices trading lower on coronavirus fears, but Passage Bio Inc. took a chan